The global fertility test market size was valued at USD 680.41 million in 2025 and is projected to grow from USD 735.52 million in 2026 to USD 1371.52 million by 2034, registering a CAGR of 8.1% during the forecast period from 2026 to 2034. Asia Pacific dominated the fertility test market with a market share of 36.5% in 2025.
Fertility tests are diagnostic tools and procedures used to assess an individual's or couple's reproductive health and identify factors that may affect the ability to conceive. These tests evaluate different aspects of fertility, including ovulation, hormone levels, ovarian reserve, sperm count and quality, reproductive anatomy, and overall reproductive function. Fertility testing can involve blood tests, urine-based ovulation tests, ultrasound imaging, semen analysis, and other diagnostic procedures. The market includes fertility testing kits, laboratory tests, diagnostic devices, and related services used in hospitals, fertility clinics, diagnostic laboratories, and home-care settings.
Download a Free Sample To learn more about this report,
Digital and Connected Fertility Testing Improves Personalized Reproductive Monitoring
The fertility test market is increasingly shifting toward digital fertility monitors, smartphone-connected testing kits, and hormone-tracking platforms that provide users with more detailed reproductive health information. These solutions can combine test results with cycle data and digital analytics to help users identify fertile windows more conveniently than conventional test strips alone. The growing availability of home-based testing and connected health technologies is also improving accessibility and encouraging consumers to monitor fertility outside traditional clinical settings.
At-Home Fertility Testing Expands Beyond Basic Ovulation Tracking
Fertility testing is increasingly moving toward convenient, home-based solutions that allow individuals to monitor reproductive health privately and without frequent clinical visits. While ovulation prediction kits remain widely used, manufacturers are expanding into hormone testing, fertility monitors, and male fertility assessment products. Improvements in test sensitivity, digital interpretation, and mobile connectivity are making home-based testing more accessible and useful for consumers planning conception.
Greater Fertility Awareness Encourages Early Testing and Reproductive Health Monitoring
Growing awareness of infertility and reproductive health is encouraging individuals and couples to seek fertility information and testing earlier. Awareness campaigns, educational initiatives, fertility-focused digital platforms, and greater discussion of reproductive health are helping reduce the stigma surrounding infertility and increasing consumer interest in fertility assessment. The availability of accessible home-testing products is further supporting this shift by allowing individuals to monitor fertility indicators before seeking clinical evaluation.
Hormonal Variability in PCOS Can Reduce the Reliability of Ovulation Tests
Ovulation tests primarily detect hormonal changes associated with the fertile window, but hormonal irregularities can make results difficult to interpret for some users. Women with polycystic ovary syndrome (PCOS) may experience elevated or fluctuating luteinizing hormone levels, potentially producing multiple LH surges or misleading results. This limitation can reduce consumer confidence in ovulation-prediction tests and encourage users to seek more comprehensive clinical fertility assessments.
E-Commerce Expansion Broadens Access to At-Home Fertility Testing
The rapid expansion of e-commerce and direct-to-consumer healthcare platforms is creating new opportunities for fertility test manufacturers. Consumers can purchase ovulation tests, pregnancy tests, hormone-monitoring kits, and fertility tracking devices online without requiring a routine clinic visit. Online channels also allow companies to provide educational content, subscriptions, digital tracking applications, and personalized fertility services alongside physical testing products, creating broader opportunities for direct engagement with consumers.
Accuracy and Interpretation Limitations Require More Comprehensive Fertility Assessment
Fertility tests face the challenge of providing reliable results across users with different hormonal profiles, ages, menstrual patterns, and reproductive conditions. Home ovulation tests can identify hormonal changes associated with the fertile window but do not necessarily confirm that ovulation has occurred. Medications, irregular cycles, PCOS, and other reproductive factors can further complicate interpretation. Manufacturers therefore need to improve test sensitivity, digital interpretation, and integration with multiple fertility biomarkers to provide consumers with more meaningful results.
The fertility test market is segmented into Ovulation Prediction Kits, Fertility Monitors, Urine-based Ovulation Test Kits, Saliva-based Ovulation Test Kits, and Male Fertility Test Kits. Ovulation Prediction Kits held the leading position, accounting for 34.6% of the market share in 2025. Their dominance is supported by their affordability, convenience, ease of use, and ability to help users identify the fertile window through hormonal changes.
Request Customizationto receive a tailored report.
The market is segmented into OTC-based and Prescription-based products. OTC-based fertility tests are the fastest-growing segment, projected to register an 8.3% CAGR from 2026 to 2034. Growth is driven by the convenience of purchasing fertility tests without a prescription, increasing availability through pharmacies and online platforms, and rising consumer preference for private and accessible reproductive health testing. The expansion of direct-to-consumer fertility products is also supporting the segment's growth.
The fertility test market is segmented into Female Fertility Testing and Male Fertility Testing. Female Fertility Testing accounted for the leading share of 84.6% in 2025. The segment's dominance is supported by the widespread use of ovulation prediction kits, hormone tests, and fertility monitors for identifying fertile periods and assessing reproductive health. Increasing awareness of female fertility, delayed family planning, and growing use of home-based reproductive health products are further contributing to segment growth.
The market is segmented into Home Care Settings and Fertility Clinics. Home Care Settings represent the fastest-growing segment, projected to expand at an 8.4% CAGR from 2026 to 2034. Growth is driven by increasing consumer preference for convenient and private fertility testing, wider availability of over-the-counter products, and the expansion of digital fertility monitoring technologies. Smartphone-connected fertility devices and at-home hormone testing are further improving accessibility and encouraging consumers to monitor reproductive health outside clinical environments.
Speak to an Analystto discuss market opportunities.
Asia Pacific held the largest share of the global fertility test market in 2025, accounting for 36.5%, with a market value of USD 0.25 billion. The regional market is projected to grow at a 8.2% CAGR during the forecast period. Growth is supported by increasing fertility awareness, rising healthcare expenditure, expanding access to reproductive health services, and growing adoption of home-based fertility testing.
Japan's fertility test market is supported by increasing awareness of reproductive health, delayed childbearing, and growing demand for fertility assessment among couples. The country's aging population and declining birth rate are encouraging greater attention to fertility management and assisted reproductive care. Increasing availability of home-based ovulation tests and digital fertility monitoring products is also supporting market growth.
China represents a significant market for fertility testing, supported by its large population and increasing focus on reproductive health. Greater awareness of fertility issues, changing family-planning patterns, and increasing access to healthcare services are creating demand for fertility testing products. The expansion of online healthcare and e-commerce channels is also making home-based ovulation and pregnancy testing products more accessible.
Unlock Regional Insightsto access country-level data, & regional trends.
North America accounted for 29.4% of the global fertility test market in 2025, with a market value of USD 0.20 billion. The regional market is expected to grow at a 7.6% CAGR during the forecast period. Growth is driven by high consumer awareness of fertility and reproductive health, increased use of home-based testing, and strong availability of advanced fertility monitoring technologies.
The United States is the leading market for fertility testing in North America, supported by high awareness of reproductive health and widespread availability of fertility testing products. Increasing use of ovulation prediction kits, hormone-monitoring devices, and digital fertility applications is supporting demand for at-home testing. Growing utilization of fertility services and delayed family planning are also encouraging consumers to monitor reproductive health earlier.
Canada's fertility test market is supported by increasing awareness of infertility and reproductive health and growing access to fertility services. The availability of over-the-counter ovulation and pregnancy testing products is encouraging home-based fertility monitoring. Increasing adoption of digital health technologies and online purchasing channels is also improving consumer access to fertility testing solutions.
Europe represented 24.1% of the global fertility test market in 2025, with a market value of USD 0.16 billion. The regional market is projected to register an 8.9% CAGR, the highest among the major regions. Growth is supported by increasing awareness of fertility challenges, delayed parenthood, declining fertility rates, and growing utilization of reproductive healthcare services.
Germany's fertility test market is supported by increasing awareness of reproductive health and growing demand for fertility assessment among couples delaying parenthood. The country's established healthcare infrastructure provides access to both clinical fertility testing and over-the-counter home-testing products. Increasing use of digital fertility tracking and ovulation monitoring is also supporting market expansion.
The United Kingdom's fertility test market is driven by growing awareness of infertility, delayed childbearing, and increasing interest in reproductive health monitoring. Consumers are increasingly using home-based ovulation and fertility testing products to identify fertile periods before seeking clinical assistance. The expansion of digital fertility applications and online distribution channels is further improving access to testing products.
Latin America accounted for 5.8% of the global fertility test market in 2025, with a market value of USD 0.04 billion. The regional market is expected to grow at a 7.1% CAGR during the forecast period. Growth is supported by improving access to reproductive healthcare, increasing fertility awareness, and greater availability of affordable home-based testing products. The expansion of online retail and digital health services is also creating additional opportunities for fertility test manufacturers.
Brazil is a major market for fertility testing in Latin America, supported by its large population, expanding healthcare sector, and increasing awareness of reproductive health. Growing interest in home-based ovulation and fertility monitoring is creating demand for convenient testing products. Wider availability through pharmacies and online platforms is also improving access to fertility tests across the country.
The Middle East and Africa accounted for 4.2% of the global fertility test market in 2025, with a market value of USD 0.03 billion. The regional market is projected to grow at a 6.8% CAGR. Growth is supported by improving healthcare infrastructure, increasing awareness of fertility and reproductive health, and expanding access to diagnostic services.
The UAE's fertility test market is supported by its advanced healthcare infrastructure, growing fertility-care services, and increasing awareness of reproductive health. The country has developed into an important regional healthcare and medical tourism hub, supporting demand for fertility assessment and monitoring.
The fertility test market is competitive, with companies focusing on ovulation prediction kits, fertility monitors, saliva- and urine-based testing, and digital fertility tracking solutions. Key market participants include Church & Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products Inc., Prestige Brands Holdings Inc., Quidel Corporation, Abbott Laboratories, UEBE Medical, and AdvaCare Pharma. Companies are strengthening their market positions through home-based testing, reusable monitoring devices, digital fertility applications, and products designed to provide convenient reproductive health monitoring.
HiLin Life Products Inc. is strengthening its position in the fertility test market through its KNOWHEN® Advanced Saliva Ovulation Test and Fertility Monitor App. The company specializes in reusable saliva-based fertility testing, allowing users to monitor changes in saliva associated with the fertile period. Its integrated mobile application enables users to record fertility observations, track cycles, and receive fertility-related alerts, supporting convenient home-based reproductive health monitoring.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Mass Spectrometry Market Size, Share, Growth, Analysis, 2034
Blood Testing Market Size, Share, Growth, Analysis, Report, 2034
3D Cell Culture Market Size, Share, Growth, Analysis, Report, 2034
3D Bioprinting Market Size, Share, Growth, Analysis, Report, 2034
United Kingdom Epigenetics Market Size, Trends, Top Share and Forecast to 2034
Bovine Serum Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com